Paper23348993
Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents.
Matos MJ and 6 others. Molecules, 2013. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents. Papers, record 23348993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23348993
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amines | Major topic |
| Anti-Bacterial Agents | Major topic |
| Coumarins | Major topic |
| Nitro Compounds | Major topic |
| Dicumarol | |
| Escherichia coli | |
| Microbial Sensitivity Tests | |
| Novobiocin | |
| Staphylococcus aureus | |
| Structure-Activity Relationship |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10450985 | Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B. | Bioorg Med Chem Lett | 1999 | https://conductscience.org/library/papers/10450985 | PubMed |
| 2 | 17682095 | Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17682095 | PubMed |
| 3 | 20630755 | Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. | Bioorg Med Chem Lett | 2010 | https://conductscience.org/library/papers/20630755 | PubMed |
| 4 | 18251491 | Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships. | J Med Chem | 2008 | https://conductscience.org/library/papers/18251491 | PubMed |
| 5 | 6295263 | Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6295263 | PubMed |
| 6 | 21316817 | Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives. | Eur J Med Chem | 2011 | https://conductscience.org/library/papers/21316817 | PubMed |
| 7 | 16881035 | Antibacterial natural products in medicinal chemistry--exodus or revival? | Angew Chem Int Ed Engl | 2006 | https://conductscience.org/library/papers/16881035 | PubMed |
| 8 | 17655212 | Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. | J Med Chem | 2007 | https://conductscience.org/library/papers/17655212 | PubMed |
| 9 | 21215620 | Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents. | Bioorg Med Chem Lett | 2011 | https://conductscience.org/library/papers/21215620 | PubMed |
| 10 | 15496893 | Antibiotics at the crossroads. | Nature | 2004 | https://conductscience.org/library/papers/15496893 | PubMed |
| 11 | 19628387 | Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors. | Bioorg Med Chem Lett | 2009 | https://conductscience.org/library/papers/19628387 | PubMed |
| 12 | 22779756 | Looking for new targets: simple coumarins as antibacterial agents. | Med Chem | 2012 | https://conductscience.org/library/papers/22779756 | PubMed |
| 13 | 11215328 | Antimicrobial activity of new coumarin derivatives. | Arzneimittelforschung | 2001 | https://conductscience.org/library/papers/11215328 | PubMed |
| 14 | 21923181 | Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors. | J Med Chem | 2011 | https://conductscience.org/library/papers/21923181 | PubMed |
| 15 | 21216502 | Synthesis of 4H-chromene, coumarin, 12H-chromeno[2,3-d]pyrimidine derivatives and some of their antimicrobial and cytotoxicity activities. | Eur J Med Chem | 2011 | https://conductscience.org/library/papers/21216502 | PubMed |
| 16 | 19423346 | A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors. | Bioorg Med Chem Lett | 2009 | https://conductscience.org/library/papers/19423346 | PubMed |
| 17 | 20409723 | Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents. | Bioorg Med Chem | 2010 | https://conductscience.org/library/papers/20409723 | PubMed |
| 19 | 20659799 | New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors. | Bioorg Med Chem Lett | 2010 | https://conductscience.org/library/papers/20659799 | PubMed |
| 20 | 18977661 | Synthesis and antimicrobial activity of 2-alkenylchroman-4-ones, 2-alkenylthiochroman-4-ones and 2-alkenylquinol-4-ones. | Bioorg Med Chem | 2008 | https://conductscience.org/library/papers/18977661 | PubMed |
| 21 | 19633620 | Tyrosinase inhibitor activity of coumarin-resveratrol hybrids. | Molecules | 2009 | https://conductscience.org/library/papers/19633620 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40725260 | Advanced Research on Biological Properties-A Study on the Activity of the Apis mellifera Antioxidant System and the Crystallographic and Spectroscopic Properties of 7-Diethylamino-4-hydroxycoumarin. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725260 | PubMed |
| 40213246 | Synergistic effects of doxorubicin and coumarin on colorectal cancer cell proliferation and EMT modulation: in silico and in vitro study. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40213246 | PubMed |
| 39665231 | Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms. | Microbiologyopen | 2024 | https://conductscience.org/library/papers/39665231 | PubMed |
| 36615454 | Design, Catalyst-Free Synthesis of New Novel α-Trifluoromethylated Tertiary Alcohols Bearing Coumarins as Potential Antifungal Agents. | Molecules | 2022 | https://conductscience.org/library/papers/36615454 | PubMed |
| 35821884 | Metal-free domino amination-Knoevenagel condensation approach to access new coumarins as potent nanomolar inhibitors of VEGFR-2 and EGFR. | Green Chem Lett Rev | 2021 | https://conductscience.org/library/papers/35821884 | PubMed |
| 35625352 | Filamentous Thermosensitive Mutant Z: An Appealing Target for Emerging Pathogens and a Trek on Its Natural Inhibitors. | Biology (Basel) | 2022 | https://conductscience.org/library/papers/35625352 | PubMed |
| 35438580 | Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives. | J Enzyme Inhib Med Chem | 2022 | https://conductscience.org/library/papers/35438580 | PubMed |
| 34946609 | Retrieval of High Added Value Natural Bioactive Coumarins from Mandarin Juice-Making Industrial Byproduct. | Molecules | 2021 | https://conductscience.org/library/papers/34946609 | PubMed |
| 34771164 | 3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade. | Molecules | 2021 | https://conductscience.org/library/papers/34771164 | PubMed |
| 33405018 | Analysis of Fluorescence Quenching of Coumarin Derivative under Steady State and Transient State Methods. | J Fluoresc | 2021 | https://conductscience.org/library/papers/33405018 | PubMed |
| 31375003 | Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins. | Molecules | 2019 | https://conductscience.org/library/papers/31375003 | PubMed |
| 28617340 | Coumarin-Tetrapyrrolic Macrocycle Conjugates: Synthesis and Applications. | Molecules | 2017 | https://conductscience.org/library/papers/28617340 | PubMed |
| 24077176 | Synthesis and antibacterial evaluation of some novel imidazole and benzimidazole sulfonamides. | Molecules | 2013 | https://conductscience.org/library/papers/24077176 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23348993
GET https://conductscience.org/api/papers/v1/23348993/references?page=2